Sleep- and circadian rhythm-associated pathways as therapeutic targets in bipolar disorder

Expert Opinion on Therapeutic Targets

Volumn 19, Issue 6, 2015, Pages 747-763

  Bellivier, Frank ^a,b,c,d   Geoffroy, Pierre Alexis ^a,b,c,d   Etain, Bruno ^d,e,f   Scott, Jan ^g,h  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^d FONDATION FONDAMENTAL   (France)

^e INSERM U955   (France)

^f HENRI MONDOR HOSPITAL   (France)

^g NEWCASTLE UNIVERSITY   (United Kingdom)

^h KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Bipolar disorders; Circadian rhythm; Sleep; Therapeutic response

Indexed keywords

HYDROCORTISONE; LITHIUM; MELATONIN; NEUROTRANSMITTER; LITHIUM DERIVATIVE;

ACTIMETRY; BIPOLAR DEPRESSION; BIPOLAR DISORDER; CHRONOTHERAPY; CIRCADIAN RHYTHM; DNA POLYMORPHISM; GENETIC ASSOCIATION; GENETIC MARKER; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INTERVENTION STUDY; INVESTIGATIVE PROCEDURES; META ANALYSIS; MOLECULAR CLOCK; NONHUMAN; PHARMACOGENETICS; PHENOTYPE; PHOTOTHERAPY; RELAPSE; REVIEW; SLEEP DEPRIVATION; SLEEP PATTERN; SLEEP WAKING CYCLE; ANIMAL; CHRONOBIOLOGY DISORDERS; DRUG DESIGN; DRUG EFFECTS; GENETIC POLYMORPHISM; GENETICS; MOLECULARLY TARGETED THERAPY; PATHOPHYSIOLOGY; SLEEP WAKE DISORDERS;

ANIMALS; BIPOLAR DISORDER; CHRONOBIOLOGY DISORDERS; CIRCADIAN RHYTHM; DRUG DESIGN; HUMANS; LITHIUM COMPOUNDS; MOLECULAR TARGETED THERAPY; PHARMACOGENETICS; POLYMORPHISM, GENETIC; SLEEP WAKE DISORDERS;

EID: 84929573832     PISSN: 14728222     EISSN: 17447631     Source Type: Journal    
DOI: 10.1517/14728222.2015.1018822     Document Type: Review

References (199)

1. Scott J. Clinical parameters of circadian rhythms in affective disorders. Eur Neuropsychopharmacol 2011;21(Suppl 4):S671-5
2. Gonzalez R. The relationship between bipolar disorder and biological rhythms. J Clin Psychiatry 2014;75(4):e323-31
3. Etain B, Milhiet V, Bellivier F, et al. Genetics of circadian rhythms and mood spectrum disorders. Eur Neuropsychopharmacol 2011;21(Suppl 4):S676-82
4. Sylvia LG, Dupuy JM, Ostacher MJ, et al. Sleep disturbance in euthymic bipolar patients. J Psychopharmacol 2012;26(8):1108-12
5. Kaplan KA, Gruber J, Eidelman P, et al. Hypersomnia in inter-episode bipolar disorder: does it have prognostic significance? J Affect Disord 2011;132(3):438-44
6. Grandin LD, Alloy LB, Abramson LY. The social zeitgeber theory, circadian rhythms, and mood disorders: review and evaluation. Clin Psychol Rev 2006;26(6):679-94
7. Takahashi JS, Hong H-K, Ko CH, et al. The genetics of mammalian circadian order and disorder: implications for physiology and disease. Nat Rev Genet 2008;9(10):764-75
8. Dardente H, Cermakian N. Molecular circadian rhythms in central and peripheral clocks in mammals. Chronobiol Int 2007;24(2):195-213
9. Martinek S, Inonog S, Manoukian AS, et al. A role for the segment polarity gene shaggy/GSK-3 in the Drosophila circadian clock. Cell 2001;105(6):769-79
10. Yin L, Wang J, Klein PS, et al. Nuclear receptor Rev-erbalpha is a critical lithium-sensitive component of the circadian clock. Science 2006;311(5763):1002-5
11. Bellet MM, Sassone-Corsi P. Mammalian circadian clock and metabolism - the epigenetic link. J Cell Sci 2010;123(Pt 22):3837-48
12. Bell-Pedersen D, Cassone VM, Earnest DJ, et al. Circadian rhythms from multiple oscillators: lessons from diverse organisms. Nat Rev Genet 2005;6(7):544-56
13. Yamazaki S, Numano R, Abe M, et al. Resetting central and peripheral circadian oscillators in transgenic rats. Science 2000;288(5466):682-5
14. Hastings M, O'Neill JS, Maywood ES. Circadian clocks: regulators of endocrine and metabolic rhythms. J Endocrinol 2007;195(2):187-98
15. Panda S, Antoch MP, Miller BH, et al. Coordinated transcription of key pathways in the mouse by the circadian clock. Cell 2002;109(3):307-20
16. Lewy AJ, Wehr TA, Goodwin FK, et al. Light suppresses melatonin secretion in humans. Science 1980;210(4475):1267-9
17. Zeitzer JM, Dijk DJ, Kronauer R, et al. Sensitivity of the human circadian pacemaker to nocturnal light: melatonin phase resetting and suppression. J Physiol 2000;526(Pt 3):695-702
18. Benloucif S, Burgess HJ, Klerman EB, et al. Measuring melatonin in humans. J Clin Sleep Med 2008;4(1):66-9
19. Lewy AJ, Sack RL. The dim light melatonin onset as a marker for circadian phase position. Chronobiol Int 1989;6(1):93-102
20. Hofstra WA, de Weerd AW. How to assess circadian rhythm in humans: a review of literature. Epilepsy Behav 2008;13(3):438-44
21. Wesemann W, Weiner N. Circadian rhythm of serotonin binding in rat brain. Prog Neurobiol 1990;35(6):405-28
22. Weiner N, Clement HW, Gemsa D, et al. Circadian and seasonal rhythms of 5-HT receptor subtypes, membrane anisotropy and 5-HT release in hippocampus and cortex of the rat. Neurochem Int 1992;21(1):7-14
23. Barassin S, Raison S, Saboureau M, et al. Circadian tryptophan hydroxylase levels and serotonin release in the suprachiasmatic nucleus of the rat. Eur J Neurosci 2002;15(5):833-40
24. Shieh KR, Chu YS, Pan JT. Circadian change of dopaminergic neuron activity: effects of constant light and melatonin. Neuroreport 1997;8(9-10):2283-7
25. Khaldy H, León J, Escames G, et al. Circadian rhythms of dopamine and dihydroxyphenyl acetic acid in the mouse striatum: effects of pinealectomy and of melatonin treatment. Neuroendocrinology 2002;75(3):201-8
26. Castañeda TR, de Prado BM, Prieto D, et al. Circadian rhythms of dopamine, glutamate and GABA in the striatum and nucleus accumbens of the awake rat: modulation by light. J Pineal Res 2004;36(3):177-85
27. Akhisaroglu M, Kurtuncu M, Manev H, et al. Diurnal rhythms in quinpiroleinduced locomotor behaviors and striatal D2/D3 receptor levels in mice. Pharmacol Biochem Behav 2005;80(3):371-7
28. Coon SL, McCune SK, Sugden D, et al. Regulation of pineal alpha1B-adrenergic receptor mRNA: day/night rhythm and beta-adrenergic receptor/cyclic AMP control. Mol Pharmacol 1997;51(4):551-7
29. Aston-Jones G, Chen S, Zhu Y, et al. A neural circuit for circadian regulation of arousal. Nat Neurosci 2001;4(7):732-8
30. Morin LP. Serotonin and the regulation of mammalian circadian rhythmicity. Ann Med 1999;31(1):12-33
31. Moore CM, Demopulos CM, Henry ME, et al. Brain-to-serum lithium ratio and age: an in vivo magnetic resonance spectroscopy study. Am J Psychiatry 2002;159(7):1240-2
32. Hannibal J, Fahrenkrug J. Neuronal input pathways to the brain's biological clock and their functional significance. Adv Anat Embryol Cell Biol 2006;182:1-71
33. Reghunandanan V, Reghunandanan R. Neurotransmitters of the suprachiasmatic nuclei. J Circadian Rhythms 2006;4:2
34. Ying SW, Rusak B. Effects of serotonergic agonists on firing rates of photically responsive cells in the hamster suprachiasmatic nucleus. Brain Res 1994;651(1-2):37-46
35. Rea MA, Barrera J, Glass JD, et al. Serotonergic potentiation of photic phase shifts of the circadian activity rhythm. Neuroreport 1995;6(10):1417-20
36. Fite KV, Janusonis S, Foote W, et al. Retinal afferents to the dorsal raphe nucleus in rats and Mongolian gerbils. J Comp Neurol 1999;414(4):469-84
37. Jiang ZG, Teshima K, Yang Y, et al. Pre- and postsynaptic actions of serotonin on rat suprachiasmatic nucleus neurons. Brain Res 2000;866(1-2):247-56
38. Lambert GW, Reid C, Kaye DM, et al. Effect of sunlight and season on serotonin turnover in the brain. Lancet 2002;360(9348):1840-2
39. Yuan Q, Lin F, Zheng X, et al. Serotonin modulates circadian entrainment in Drosophila. Neuron 2005;47(1):115-27
40. Snyder SH, Borjigin J, Sassone-Corsi P. Discovering light effects on the brain. Am J Psychiatry 2006;163(5):771
41. Witkovsky P. Dopamine and retinal function. Doc Ophthalmol 2004;108(1):17-40
42. Monti JM, Monti D. The involvement of dopamine in the modulation of sleep and waking. Sleep Med Rev 2007;11(2):113-33
43. Lima MM, Andersen ML, Reksidler AB, et al. Blockage of dopaminergic D(2) receptors produces decrease of REM but not of slow wave sleep in rats after REM sleep deprivation. Behav Brain Res 2008;188(2):406-11
44. Yujnovsky I, Hirayama J, Doi M, et al. Signaling mediated by the dopamine D2 receptor potentiates circadian regulation by CLOCK:BMAL1. Proc Natl Acad Sci USA 2006;103(16):6386-91
45. Simonneaux V, Ribelayga C. Generation of the melatonin endocrine message in mammals: a review of the complex regulation of melatonin synthesis by norepinephrine, peptides, and other pineal transmitters. Pharmacol Rev 2003;55(2):325-95
46. Murray G, Harvey A. Circadian rhythms and sleep in bipolar disorder. Bipolar Disord 2010;12(5):459-72
47. Milhiet V, Boudebesse C, Bellivier F, et al. Circadian abnormalities as markers of susceptibility in bipolar disorders. Front Biosci (Schol Ed) 2014;6:120-37
48. Horne JA, Ostberg O. A self-assessment questionnaire to determine morningness-eveningness in human circadian rhythms. Int J Chronobiol 1976;4(2):97-110
49. Smith CS, Reilly C, Midkiff K. Evaluation of three circadian rhythm questionnaires with suggestions for an improved measure of morningness. J Appl Psychol 1989;74(5):728-38
50. Zavada A, Gordijn MC, Beersma DG, et al. Comparison of the munich chronotype questionnaire with the horneostberg's morningness-eveningness score. Chronobiol Int 2005;22(2):267-78
51. Vink JM, Groot AS, Kerkhof GA, et al. Genetic analysis of morningness and eveningness. Chronobiol Int 2001;18(5):809-22
52. Klei L, Reitz P, Miller M, et al. Heritability of morningness-eveningness and self-report sleep measures in a family-based sample of 521 hutterites. Chronobiol Int 2005;22(6): 1041-54
53. Koskenvuo M, Hublin C, Partinen M, et al. Heritability of diurnal type: a nationwide study of 8753 adult twin pairs. J Sleep Res 2007;16(2): 156-62
54. Barclay NL, Eley TC, Buysse DJ, et al. Diurnal preference and sleep quality: same genes? A study of young adult twins. Chronobiol Int 2010;27(2):278-96
55. Hakkarainen R, Johansson C, Kieseppä T, et al. Seasonal changes, sleep length and circadian preference among twins with bipolar disorder. BMC Psychiatry 2003;3:6
56. Kerkhof GA, Van Dongen HP. Morning-type and evening-type individuals differ in the phase position of their endogenous circadian oscillator. Neurosci Lett 1996;218(3):153-6
57. Duffy JF, Rimmer DW, Czeisler CA. Association of intrinsic circadian period with morningness-eveningness, usual wake time, and circadian phase. Behav Neurosci 2001;115(4): 895-9
58. Burgess HJ, Fogg LF. Individual differences in the amount and timing of salivary melatonin secretion. PLoS One 2008;3(8):e3055
59. Randler C, Schaal S. Morningness-Eveningness, habitual sleep-wake variables and cortisol level. Biol Psychol 2010;85(1):14-18
60. Caci H, Nadalet L, Staccini P, et al. The composite scale of morningness: further psychometric properties and temporal stability. Eur Psychiatry 2000;15(4):278-81
61. Greenwood KM. Long-term stability and psychometric properties of the Composite Scale of Morningness. Ergonomics 1994;37(2):377-83
62. Wood J, Birmaher B, Axelson D, et al. Replicable differences in preferred circadian phase between bipolar disorder patients and control individuals. Psychiatry Res 2009;166(2-3):201-9
63. Ahn YM, Chang J, Joo YH, et al. Chronotype distribution in bipolar I disorder and schizophrenia in a Korean sample. Bipolar Disord 2008;10(2):271-5
64. Mansour HA, Wood J, Chowdari KV, et al. Circadian phase variation in bipolar I disorder. Chronobiol Int 2005;22(3):571-84
65. Boudebesse C, Lajnef M, Geoffroy PA, et al. Chronotypes of bipolar patients in remission: validation of the French version of the circadian type inventory in the FACE-BD sample. Chronobiol Int 2013;30(8):1042-9
66. Di Milia L, Smith PA, Folkard S. A validation of the revised circadian type inventory in a working sample. Personal Individ Differ 2005;39(7):1293-305
67. Chung JK, Lee KY, Kim SH, et al. Circadian rhythm characteristics in mood disorders: comparison among bipolar I disorder, bipolar II disorder and recurrent major depressive disorder. Clin Psychopharmacol Neurosci 2012;10(2):110-16
68. Ottoni GL, Antoniolli E, Lara DR. Circadian preference is associated with emotional and affective temperaments. Chronobiol Int 2012;29(6):786-93
69. Kaplan KA, Talbot LS, Gruber J, et al. Evaluating sleep in bipolar disorder: comparison between actigraphy, polysomnography, and sleep diary. Bipolar Disord 2012;14(8):870-9
70. Sitaram N, Nurnberger JI Jr, Gershon ES, et al. Cholinergic regulation of mood and REM sleep: potential model and marker of vulnerability to affective disorder. Am J Psychiatry 1982;139(5):571-6
71. Knowles JB, Cairns J, MacLean AW, et al. The sleep of remitted bipolar depressives: comparison with sex and agematched controls. Can J Psychiatry 1986;31(4):295-8
72. Geoffroy PA, Boudebesse C, Bellivier F, et al. Sleep in remitted bipolar disorder: a naturalistic case-control study using actigraphy. J Affect Disord 2014;158:1-7
73. Gershon A, Thompson WK, Eidelman P, et al. Restless pillow, ruffled mind: sleep and affect coupling in interepisode bipolar disorder. J Abnorm Psychol 2012;121(4):863-73
74. Harvey AG, Schmidt DA, Scarnà A, et al. Sleep-related functioning in euthymic patients with bipolar disorder, patients with insomnia, and subjects without sleep problems. Am J Psychiatry 2005;162(1):50-7
75. Jones SH, Hare DJ, Evershed K. Actigraphic assessment of circadian activity and sleep patterns in bipolar disorder. Bipolar Disord 2005;7(2):176-86
76. Millar A, Espie CA, Scott J. The sleep of remitted bipolar outpatients: a controlled naturalistic study using actigraphy. J Affect Disord 2004;80(2-3):145-53
77. Mullin BC, Harvey AG, Hinshaw SP. A preliminary study of sleep in adolescents with bipolar disorder, ADHD, and non-patient controls. Bipolar Disord 2011;13(4):425-32
78. Ritter PS, Marx C, Lewtschenko N, et al. The characteristics of sleep in patients with manifest bipolar disorder, subjects at high risk of developing the disease and healthy controls. J Neural Transm 2012;119(10):1173-84
79. Salvatore P, Ghidini S, Zita G, et al. Circadian activity rhythm abnormalities in ill and recovered bipolar I disorder patients. Bipolar Disord 2008;10(2):256-65
80. Ankers D, Jones SH. Objective assessment of circadian activity and sleep patterns in individuals at behavioural risk of hypomania. J Clin Psychol 2009;65(10):1071-86
81. Geoffroy PA, Scott J, Boudebesse C, et al. Sleep in patients with remitted bipolar disorders: a meta-analysis of actigraphy studies. Acta Psychiatr Scand 2014;131(2):89-99
82. Robillard R, Naismith SL, Rogers NL, et al. Delayed sleep phase in young people with unipolar or bipolar affective disorders. J Affect Disord 2013;145(2):260-3
83. Jones SH, Tai S, Evershed K, et al. Early detection of bipolar disorder: a pilot familial high-risk study of parents with bipolar disorder and their adolescent children. Bipolar Disord 2006;8(4):362-72
84. Hamet P, Tremblay J. Genetics of the sleep-wake cycle and its disorders. Metabolism 2006;55(10 Suppl 2):S7-12
85. Dauvilliers Y, Maret S, Tafti M. Genetics of normal and pathological sleep in humans. Sleep Med Rev 2005;9(2):91-100
86. Janney CA, Fagiolini A, Swartz HA, et al. Are adults with bipolar disorder active? Objectively measured physical activity and sedentary behavior using accelerometry. J Affect Disord 2014;152-154:498-504
87. Monk TH, Reynolds CF, Buysse DJ, et al. The relationship between lifestyle regularity and subjective sleep quality. Chronobiol Int 2003;20(1):97-107
88. Monk TH, Buysse DJ, Potts JM, et al. Morningness-eveningness and lifestyle regularity. Chronobiol Int 2004;21(3):435-43
89. Sylvia LG, Alloy LB, Hafner JA, et al. Life events and social rhythms in bipolar spectrum disorders: a prospective study. Behav Ther 2009;40(2):131-41
90. Giglio LM, Magalhães PV, Andreazza AC, et al. Development and use of a biological rhythm interview. J Affect Disord 2009;118(1-3):161-5
91. Meyer TD, Maier S. Is there evidence for social rhythm instability in people at risk for affective disorders? Psychiatry Res 2006;141(1):103-14
92. Shen GH, Alloy LB, Abramson LY, et al. Social rhythm regularity and the onset of affective episodes in bipolar spectrum individuals. Bipolar Disord 2008;10(4):520-9
93. Malkoff-Schwartz S, Frank E, Anderson B, et al. Stressful life events and social rhythm disruption in the onset of manic and depressive bipolar episodes: a preliminary investigation. Arch Gen Psychiatry 1998;55(8):702-7
94. Cervantes P, Gelber S, Kin FN, et al. Circadian secretion of cortisol in bipolar disorder. J Psychiatry Neurosci 2001;26(5):411-16
95. Deshauer D, Duffy A, Alda M, et al. The cortisol awakening response in bipolar illness: a pilot study. Can J Psychiatry 2003;48(7):462-6
96. Bartels M, Van den Berg M, Sluyter F, et al. Heritability of cortisol levels: review and simultaneous analysis of twin studies. Psychoneuroendocrinology 2003;28(2):121-37
97. Kupper N, de Geus EJC, van den Berg M, et al. Familial influences on basal salivary cortisol in an adult population. Psychoneuroendocrinology 2005;30(9):857-68
98. Franz CE, York TP, Eaves LJ, et al. Genetic and environmental influences on cortisol regulation across days and contexts in middle-aged men. Behav Genet 2010;40(4):467-79
99. Vinberg M, Bennike B, Kyvik KO, et al. Salivary cortisol in unaffected twins discordant for affective disorder. Psychiatry Res 2008;161(3):292-301
100. Wüst S, Wolf J, Hellhammer DH, et al. The cortisol awakening response-normal values and confounds. Noise Health 2000;2(7):79-88
101. Ellenbogen MA, Santo JB, Linnen A-M, et al. High cortisol levels in the offspring of parents with bipolar disorder during two weeks of daily sampling. Bipolar Disord 2010;12(1):77-86
102. Deshauer D, Duffy A, Meaney M, et al. Salivary cortisol secretion in remitted bipolar patients and offspring of bipolar parents. Bipolar Disord 2006;8(4):345-9
103. Girshkin L, Matheson SL, Shepherd AM, et al. Morning cortisol levels in schizophrenia and bipolar disorder: a meta-analysis. Psychoneuroendocrinology 2014;49:187-206
104. Lewy AJ, Nurnberger JI, Wehr TA, et al. Supersensitivity to light: possible trait marker for manic-depressive illness. Am J Psychiatry 1985;142(6):725-7
105. Nathan PJ, Burrows GD, Norman TR. Melatonin sensitivity to dim white light in affective disorders. Neuropsychopharmacology 1999;21(3):408-13
106. Lam RW, Berkowitz AL, Berga SL, et al. Melatonin suppression in bipolar and unipolar mood disorders. Psychiatry Res 1990;33(2):129-34
107. Whalley LJ, Perini T, Shering A, et al. Melatonin response to bright light in recovered, drug-free, bipolar patients. Psychiatry Res 1991;38(1):13-19
108. Nurnberger JI Jr, Adkins S, Lahiri DK, et al. Melatonin suppression by light in euthymic bipolar and unipolar patients. Arch Gen Psychiatry 2000;57(6): 572-9
109. Kennedy SH, Kutcher SP, Ralevski E, et al. Nocturnal melatonin and 24-hour 6-sulphatoxymelatonin levels in various phases of bipolar affective disorder. Psychiatry Res 1996;63(2-3):219-22
110. Nováková M, Praško J, Látalová K, et al. The circadian system of patients with bipolar disorder differs in episodes of mania and depression. Bipolar Disord 2014. [Epub ahead of print]
111. Robillard R, Naismith SL, Rogers NL, et al. Sleep-wake cycle and melatonin rhythms in adolescents and young adults with mood disorders: comparison of unipolar and bipolar phenotypes. Eur Psychiatry 2013;28(7):412-16
112. Hallam KT, Olver JS, Chambers V, et al. The heritability of melatonin secretion and sensitivity to bright nocturnal light in twins. Psychoneuroendocrinology 2006;31(7):867-75
113. Nurnberger JI Jr, Berrettini W, Tamarkin L, et al. Supersensitivity to melatonin suppression by light in young people at high risk for affective disorder. A preliminary report. Neuropsychopharmacology 1988;1(3):217-23
114. Sarrazin S, Etain B, Vederine F-E, et al. MRI exploration of pineal volume in bipolar disorder. J Affect Disord 2011;135(1-3):377-9
115. Byrne EM, Heath AC, Madden PA, et al. Testing the role of circadian genes in conferring risk for psychiatric disorders. Am J Med Genet Part B Neuropsychiatr Genet 2014;165(3):254-60
116. Lee KY, Ahn YM, Joo E-J, et al. No association of two common SNPs at position -1727 A/T, -50 C/T of GSK-3 beta polymorphisms with schizophrenia and bipolar disorder of Korean population. Neurosci Lett 2006;395(2):175-88
117. Nievergelt CM, Kripke DF, Barrett TB, et al. Suggestive evidence for association of the circadian genes PERIOD3 and ARNTL with bipolar disorder. Am J Med Genet Part B Neuropsychiatr Genet 2006;141B(3):234-41
118. Kripke DF, Nievergelt CM, Joo E, et al. Circadian polymorphisms associated with affective disorders. J Circadian Rhythms 2009;7:2
119. Lachman HM, Pedrosa E, Petruolo OA, et al. Increase in GSK3beta gene copy number variation in bipolar disorder. Am J Med Genet Part B Neuropsychiatr Genet 2007;144B(3):259-65
120. Brown SA, Fleury-Olela F, Nagoshi E, et al. The period length of fibroblast circadian gene expression varies widely among human individuals. PLoS Biol 2005;3(10):e338
121. Akashi M, Soma H, Yamamoto T, et al. Noninvasive method for assessing the human circadian clock using hair follicle cells. Proc Natl Acad Sci USA 2010;107(35):15643-8
122. Brown SA, Kunz D, Dumas A, et al. Molecular insights into human daily behavior. Proc Natl Acad Sci USA 2008;105(5):1602-7
123. Yang S, Van Dongen HP, Wang K, et al. Assessment of circadian function in fibroblasts of patients with bipolar disorder. Mol Psychiatry 2009;14(2):143-55
124. Coyle JT. What can a clock mutation in mice tell us about bipolar disorder? Proc Natl Acad Sci USA 2007;104(15):6097-8
125. Roybal K, Theobold D, Graham A, et al. Mania-like behavior induced by disruption of CLOCK. Proc Natl Acad Sci USA 2007;104(15):6406-11
126. Prickaerts J, Moechars D, Cryns K, et al. Transgenic mice overexpressing glycogen synthase kinase 3beta: a putative model of hyperactivity and mania. J Neurosci 2006;26(35):9022-9
127. Le-Niculescu H, Patel SD, Bhat M, et al. Convergent functional genomics of genome-wide association data for bipolar disorder: comprehensive identification of candidate genes, pathways and mechanisms. Am J Med Genet Part B Neuropsychiatr Genet 2009;150B(2):155-81
128. Patel SD, Le-Niculescu H, Koller DL, et al. Coming to grips with complex disorders: genetic risk prediction in bipolar disorder using panels of genes identified through convergent functional genomics. Am J Med Genet Part B Neuropsychiatr Genet 2010;153B(4):850-77
129. Benedetti F, Serretti A, Colombo C, et al. A glycogen synthase kinase 3-beta promoter gene single nucleotide polymorphism is associated with age at onset and response to total sleep deprivation in bipolar depression. Neurosci Lett 2004;368(2): 123-6
130. Benedetti F, Bernasconi A, Lorenzi C, et al. A single nucleotide polymorphism in glycogen synthase kinase 3-beta promoter gene influences onset of illness in patients affected by bipolar disorder. Neurosci Lett 2004;355(1-2): 37-40
131. Benedetti F, Dallaspezia S, Colombo C, et al. A length polymorphism in the circadian clock gene Per3 influences age at onset of bipolar disorder. Neurosci Lett 2008;445(2):184-7
132. Benedetti F, Serretti A, Pontiggia A, et al. Long-term response to lithium salts in bipolar illness is influenced by the glycogen synthase kinase 3-beta -50 T/C SNP. Neurosci Lett 2005;376(1): 51-5
133. Severino G, Manchia M, Contu P, et al. Association study in a Sardinian sample between bipolar disorder and the nuclear receptor REV-ERBalpha gene, a critical component of the circadian clock system. Bipolar Disord 2009;11(2):215-20
134. Benedetti F, Serretti A, Colombo C, et al. Influence of CLOCK gene polymorphism on circadian mood fluctuation and illness recurrence in bipolar depression. Am J Med Genet Part B Neuropsychiatr Genet 2003;123B(1):23-6
135. Shi J, Wittke-Thompson JK, Badner JA, et al. Clock genes may influence bipolar disorder susceptibility and dysfunctional circadian rhythm. Am J Med Genet Part B Neuropsychiatr Genet 2008;147B(7):1047-55
136. Lee KY, Song JY, Kim SH, et al. Association between CLOCK 3111T/C and preferred circadian phase in Korean patients with bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry 2010;34(7):1196-201
137. Etain B, Jamain S, Milhiet V, et al. Association between circadian genes, bipolar disorders and chronotypes. Chronobiol Int 2014;31(7):807-14
138. Etain B, Dumaine A, Bellivier F, et al. Genetic and functional abnormalities of the melatonin biosynthesis pathway in patients with bipolar disorder. Hum Mol Genet 2012;21(18):4030-7
139. Geoffroy PA, Boudebesse C, Henrion A, et al. An ASMT variant associated with bipolar disorder influences sleep and circadian rhythms: a pilot study. Genes Brain Behav 2014;13(3):299-304
140. Kripke DF, Klimecki WT, Nievergelt CM, et al. Circadian polymorphisms in night owls, in bipolars, and in non-24-hour sleep cycles. Psychiatry Investig 2014;11(4):345-62
141. Geoffroy P, Bellivier F, Leboyer M, et al. Can the response to mood stabilizers be predicted in bipolar disorder? Front Biosci(Elite Ed) 2014;6:120-38
142. Geoffroy PA, Etain B, Sportiche S, et al. Circadian biomarkers in patients with bipolar disorder: promising putative predictors of lithium response. Int J Bipolar Disord 2014;2(1):5
143. Freland L, Beaulieu J-M. Inhibition of GSK3 by lithium, from single molecules to signaling networks. Front Mol Neurosci 2012;5:14
144. Szczepankiewicz A, Rybakowski JK, Suwalska A, et al. Association study of the glycogen synthase kinase-3beta gene polymorphism with prophylactic lithium response in bipolar patients. World J Biol Psychiatry 2006;7(3):158-61
145. Michelon L, Meira-Lima I, Cordeiro Q, et al. Association study of the INPP1, 5HTT, BDNF, AP-2beta and GSK-3beta GENE variants and restrospectively scored response to lithium prophylaxis in bipolar disorder. Neurosci Lett 2006;403(3):288-93
146. Manchia M, Squassina A, Congiu D, et al. Interacting genes in lithium prophylaxis: preliminary results of an exploratory analysis on the role of DGKH and NR1D1 gene polymorphisms in 199 Sardinian bipolar patients. Neurosci Lett 2009;467(2):67-71
147. Campos-de-Sousa S, Guindalini C, Tondo L, et al. Nuclear receptor rev-erb-{alpha} circadian gene variants and lithium carbonate prophylaxis in bipolar affective disorder. J Biol Rhythms 2010;25(2):132-7
148. McCarthy MJ, Nievergelt CM, Shekhtman T, et al. Functional genetic variation in the Rev-Erbalpha pathway and lithium response in the treatment of bipolar disorder. Genes Brain Behav 2011;10(8):852-61
149. Szczepankiewicz A, Rybakowski JK, Suwalska A, et al. Glucocorticoid receptor polymorphism is associated with lithium response in bipolar patients. Neuro Endocrinol Lett 2011;32(4):545-51
150. Bunney BG, Bunney WE. Mechanisms of rapid antidepressant effects of sleep deprivation therapy: clock genes and circadian rhythms. Biol Psychiatry 2013;73(12):1164-71
151. Golden RN, Gaynes BN, Ekstrom RD, et al. The efficacy of light therapy in the treatment of mood disorders: a review and meta-analysis of the evidence. Am J Psychiatry 2005;162(4):656-62
152. Colombo C, Lucca A, Benedetti F, et al. Total sleep deprivation combined with lithium and light therapy in the treatment of bipolar depression: replication of main effects and interaction. Psychiatry Res 2000;95(1):43-53
153. Altshuler LL, Frye MA, Gitlin MJ. Acceleration and augmentation strategies for treating bipolar depression. Biol Psychiatry 2003;53(8): 691-700
154. Benedetti F, Barbini B, Fulgosi MC, et al. Combined total sleep deprivation and light therapy in the treatment of drug-resistant bipolar depression: acute response and long-term remission rates. J Clin Psychiatry 2005;66(12): 1535-40
155. Leibenluft E, Turner EH, Feldman-Naim S, et al. Light therapy in patients with rapid cycling bipolar disorder: preliminary results. Psychopharmacol Bull 1995;31(4):705-10
156. Sit D, Wisner KL, Hanusa BH, et al. Light therapy for bipolar disorder: a case series in women. Bipolar Disord 2007;9(8):918-27
157. Wu JC, Kelsoe JR, Schachat C, et al. Rapid and sustained antidepressant response with sleep deprivation and chronotherapy in bipolar disorder. Biol Psychiatry 2009;66(3): 298-301
158. Wehr TA, Turner EH, Shimada JM, et al. Treatment of rapidly cycling bipolar patient by using extended bed rest and darkness to stabilize the timing and duration of sleep. Biol Psychiatry 1998;43(11):822-8
159. Barbini B, Benedetti F, Colombo C, et al. Dark therapy for mania: a pilot study. Bipolar Disord 2005;7(1): 98-101
160. Phelps J. Dark therapy for bipolar disorder using amber lenses for blue light blockade. Med Hypotheses 2008;70(2):224-9
161. Kaplan KA, Harvey AG. Behavioral treatment of insomnia in bipolar disorder. Am J Psychiatry 2013;170(7):716-20
162. Steinan MK, Krane-Gartiser K, Langsrud K, et al. Cognitive behavioral therapy for insomnia in euthymic bipolar disorder: study protocol for a randomized controlled trial. Trials 2014;15:24
163. Miklowitz DJ, Scott J. Psychosocial treatments for bipolar disorder: costeffectiveness, mediating mechanisms, and future directions. Bipolar Disord 2009;11(Suppl 2):110-22
164. Frank E, Kupfer DJ, Thase ME, et al. Two-year outcomes for interpersonal and social rhythm therapy in individuals with bipolar I disorder. Arch Gen Psychiatry 2005;62(9):996-1004
165. Reinares M, Sánchez-Moreno J, Fountoulakis KN. Psychosocial interventions in bipolar disorder: what, for whom, and when. J Affect Disord 2014;156:46-55
166. McClung CA. Circadian genes, rhythms and the biology of mood disorders. Pharmacol Ther 2007;114(2):222-32
167. Abe M, Herzog ED, Block GD. Lithium lengthens the circadian period of individual suprachiasmatic nucleus neurons. Neuroreport 2000;11(14):3261-4
168. Li J, Lu W-Q, Beesley S, et al. Lithium impacts on the amplitude and period of the molecular circadian clockwork. PLoS One 2012;7(3):e33292
169. Hallam KT, Olver JS, Horgan JE, et al. Low doses of lithium carbonate reduce melatonin light sensitivity in healthy volunteers. Int J Neuropsychopharmacol 2005;8(2):255-9
170. Hallam KT, Olver JS, Norman TR. Effect of sodium valproate on nocturnal melatonin sensitivity to light in healthy volunteers. Neuropsychopharmacology 2005;30(7):1400-4
171. Castro LMR, Gallant M, Niles LP. Novel targets for valproic acid: upregulation of melatonin receptors and neurotrophic factors in C6 glioma cells. J Neurochem 2005;95(5):1227-36
172. Ogden CA, Rich ME, Schork NJ, et al. Candidate genes, pathways and mechanisms for bipolar (manicdepressive) and related disorders: an expanded convergent functional genomics approach. Mol Psychiatry 2004;9(11):1007-29
173. Leibenluft E, Feldman-Naim S, Turner EH, et al. Effects of exogenous melatonin administration and withdrawal in five patients with rapid-cycling bipolar disorder. J Clin Psychiatry 1997;58(9):383-8
174. Robertson JM, Tanguay PE. Case study: the use of melatonin in a boy with refractory bipolar disorder. J Am Acad Child Adolesc Psychiatry 1997;36(6):822-5
175. Bersani G, Garavini A. Melatonin addon in manic patients with treatment resistant insomnia. Prog Neuropsychopharmacol Biol Psychiatry 2000;24(2):185-91
176. Nierenberg AA. Low-dose buspirone, melatonin and low-dose bupropion added to mood stabilizers for severe treatment-resistant bipolar depression. Psychother Psychosom 2009;78(6):391-3
177. Norris ER, Karen Burke Correll JR, et al. A double-blind, randomized, placebo-controlled trial of adjunctive ramelteon for the treatment of insomnia and mood stability in patients with euthymic bipolar disorder. J Affect Disord 2013;144(1-2):141-7
178. De Bodinat C, Guardiola-Lemaitre B, Mocaër E, et al. Agomelatine, the first melatonergic antidepressant: discovery, characterization and development. Nat Rev Drug Discov 2010;9(8):628-42
179. Calabrese JR, Guelfi JD, Perdrizet-Chevallier C; Agomelatine Bipolar Study Group. Agomelatine adjunctive therapy for acute bipolar depression: preliminary open data. Bipolar Disord 2007;9(6):628-35
180. Eppel AB. Agomelatine adjunctive therapy for acute bipolar depression: preliminary open data. Bipolar Disord 2008;10(6):749-50; author reply 750-1
181. Fornaro M, McCarthy MJ, De Berardis D, et al. Adjunctive agomelatine therapy in the treatment of acute bipolar II depression: a preliminary open label study. Neuropsychiatr Dis Treat 2013;9:243-51
182. Boudebesse C, Geoffroy PA, Bellivier F, et al. Correlations between objective and subjective sleep and circadian markers in bipolar disorder. Chronobiol Int 2014;31(5):698-704
183. Ng TH, Chung K-F, Ho FY, et al. Sleep-wake disturbance in interepisode bipolar disorder and high-risk individuals: A systematic review and meta-analysis. Sleep Med Rev 2014;20C:46-58
184. Bauer M, Grof P, Gyulai L, et al. Using technology to improve longitudinal studies: self-reporting with ChronoRecord in bipolar disorder. Bipolar Disord 2004;6(1):67-74
185. Bauer M, Glenn T, Grof P, et al. Self-reported data from patients with bipolar disorder: frequency of brief depression. J Affect Disord 2007;101(1-3):227-33
186. Glenn T, Monteith S. New measures of mental state and behavior based on data collected from sensors, smartphones, and the Internet. Curr Psychiatry Rep 2014;16(12):523
187. Darwent D, Zhou X, van den Heuvel C, et al. The validity of temperaturesensitive ingestible capsules for measuring core body temperature in laboratory protocols. Chronobiol Int 2011;28(8):719-26
188. McCarthy MJ, Wei H, Marnoy Z, et al. Genetic and clinical factors predict lithium's effects on PER2 gene expression rhythms in cells from bipolar disorder patients. Transl Psychiatry 2013;3:e318
189. Xiao Y, Camarillo C, Ping Y, et al. The DNA methylome and transcriptome of different brain regions in schizophrenia and bipolar disorder. PLoS One 2014;9(4):e95875
190. Akula N, Barb J, Jiang X, et al. RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms and GTPase binding in bipolar disorder. Mol Psychiatry 2014;19(11): 1179-85
191. Van Enkhuizen J, Minassian A, Young JW. Further evidence for Clockdelta19 mice as a model for bipolar disorder mania using cross-species tests of exploration and sensorimotor gating. Behav Brain Res 2013;249:44-54
192. McClung CA. Circadian rhythms and mood regulation: insights from preclinical models. Eur Neuropsychopharmacol 2011;21(Suppl 4):S683-93
193. Jung SH, Park J-M, Moon E, et al. Delay in the recovery of normal sleepwake cycle after disruption of the lightdark cycle in mice: a bipolar disorderprone animal model? Psychiatry Investig 2014;11(4):487-91
194. Chen Z, Yoo S-H, Park Y-S, et al. Identification of diverse modulators of central and peripheral circadian clocks by high-throughput chemical screening. Proc Natl Acad Sci USA 2012;109(1):101-6
195. Chun SK, Jang J, Chung S, et al. Identification and validation of cryptochrome inhibitors that modulate the molecular circadian clock. ACS Chem Biol 2014;9(3): 703-10
196. Kozikowski AP, Gunosewoyo H, Guo S, et al. Identification of a glycogen synthase kinase-3beta inhibitor that attenuates hyperactivity in CLOCK mutant mice. ChemMedChem 2011;6(9):1593-602
197. Rybakowski JK, Dmitrzak-Weglar M, Kliwicki S, et al. Polymorphism of circadian clock genes and prophylactic lithium response. Bipolar Disord 2014;16(2):151-8
198. Leise TL. Wavelet analysis of circadian and ultradian behavioral rhythms. J Circadian Rhythms 2013;11(1):5
199. May M. Life science technologies: Big biological impacts from big data. Science 2014;344:1298-300. doi: 10.1126/science.344.6189.1298